28.05.2024  22:10:00 Zm. +0,11 Wolumen Bid15:06:11 Ask15:06:11 Kapitalizacja Rynkowa St. dywidendy Wskaźnik C/Z
1,18USD +10,28% 389 617
Obrót: 438 028,15
1,16Wolumen Bid: 200 1,21Wolumen Ask: 700 60,45 mlnUSD - 2,88

Opis działalności

Enzo Biochem is a pioneer in molecular diagnostics, leading the convergence of clinical laboratories, life sciences and therapeutics through the development of unique diagnostic platform technologies that provide numerous advantages over previous standards. A global company, Enzo Biochem utilizes cross-functional teams to develop and deploy products systems and services that meet the ever-changing and rapidly growing needs of health care both today and into the future. Underpinning Enzo Biochem’s products and technologies is a broad and deep intellectual property portfolio, with patent coverage across a number of key enabling technologies.
 

Zarząd & Rada nadzorcza

CEO
Dr. Elazar Rabbani
Zarząd
David Bench, Barry W. Weiner, Dieter Schapfel, MD, Kara Cannon
Rada nadzorcza
Dr. Elazar Rabbani, Dov Perlysky, Ian B. Walters, Mary Tagliaferri, Rebecca Fischer
 

Dane firmy

Nazwa: Enzo Biochem Inc.
Adres: 527 Madison Avenue,New York, New York 10022, USA
Telefon: +1-212-583-0100
Fax: +1-212-679-7999
E-mail: info@enzo.com
Internet: www.enzo.com
Przemysł: Biotechnologia
Sektor: Biotechnologia
Podsektor: Biotechnologia
Koniec roku finansowego: 31.07
Free float: 67,10%
Data IPO: -

Relacje inwestorskie

Nazwa: Steve Anreder
Telefon: +1-212-532-3232
Fax: -
E-mail: steven.anreder@anreder.com

Główni akcjonariusze

Freefloat
 
67,10%
Harbert Management Corp
 
11,70%
BlackRock Fund Advisors
 
7,50%
Renaissance Technologies, LLC
 
7,50%
Evermore Global Advisors LLC
 
6,20%